Animal models of lethal arrhythmias.
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 59, doi. 10.1002/ddr.10040
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2002 AND VI 55 AND IP 1
Results: 9
1
2
Safety pharmacology requirements for the development of human cardiac/cardiovascular pharmaceuticals.
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 73, doi. 10.1002/ddr.10033
- By:
- Publication type:
- Article
3
Mitochondrial K<sub>ATP</sub> channels and cardioprotection.
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 17, doi. 10.1002/ddr.10037
- By:
- Publication type:
- Article
4
Matrix metalloproteinase inhibitor development for the treatment of heart failure.
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 29, doi. 10.1002/ddr.10032
- By:
- Publication type:
- Article
5
Antiarrhythmic drug development: Historical review and future perspective.
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 3, doi. 10.1002/ddr.10036
- By:
- Publication type:
- Article
6
Antiarrhythmic drug development-illusion and disillusion?
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 1, doi. 10.1002/ddr.10035
- By:
- Publication type:
- Article
7
Stretch-activated channels in the heart: Their role in arrhythmias and potential as antiarrhythmic drug targets.
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 53, doi. 10.1002/ddr.10039
- By:
- Publication type:
- Article
8
Antiarrhythmic effects of Na-H exchange inhibition.
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 22, doi. 10.1002/ddr.10034
- By:
- Publication type:
- Article
9
Ventricular fibrillation, an uncontrolled arrhythmia seeking new targets.
- Published in:
- Drug Development Research, 2002, v. 55, n. 1, p. 45, doi. 10.1002/ddr.10038
- By:
- Publication type:
- Article